ECS International

ECS International, ECSII, Healthcare

  • Home
  • About
  • Services
  • Clients
  • Success Stories
  • Contact
  • Blog

January 20, 2022

Why Cuba’s extraordinary Covid vaccine success could provide the best hope for low-income countries

KEY POINTS Cuba’s prestigious biotech sector has developed five different Covid vaccines to date, including Abdala, Soberana 02 and Soberana Plus — all of which Cuba has said provide upwards of 90% protection against symptomatic Covid when administered in three doses.The country of roughly 11 million remains the only country in Latin America and the Caribbean to have produced a homegrown shot … [Read more...]

Filed Under: COVID-19 Pandemic, Cuba, Cuban Covid Vaccines, PAHO/WHO, Vaccine Hesitancy, WHO/PAHO

Contact Us





     

    Get In Touch

    • Email
    • Facebook
    • LinkedIn

    Copyright © 2025 ECS International

    Powered by Guild™